Genital Diseases, Female  >>  Cetrotide (cetrorelix)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

6 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cetrotide (cetrorelix) / EMD Serono
NCT00571870: Gonadotropin-releasing Hormone Antagonist on Triggering Day: A Randomized Controlled Study

Completed
N/A
80
RoW
cetrorelix acetate
Seoul National University Bundang Hospital
Infertility
08/09
08/09
NCT00460642: GnRH Antagonist to Prepare Recipients for Embryo Transfer

Completed
N/A
130
US
GnRH Antagonist (Cetrotide)
Institute for Human Reproduction (IHR)
Infertility
10/09
12/09
EMR200088-500, NCT01109654: An Observational Study of Cetrotide® Gonadotropin-releasing Hormone Antagonist (GnRH Antagonist) With GONAL-f® in Assisted Reproductive Technologies (ART)

Completed
N/A
2175
RoW
Cetrorelix acetate and Follitropin alfa, Cetrotide, Gonal-f
Merck KGaA, Darmstadt, Germany, Merck Pte. Ltd., Singapore
Infertility
12/10
12/10
NCT00867659: The Role of Cetrotide Acetate in Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in Oocyte Donors

Completed
N/A
20
US
Cetrotide acetate
Virginia Center for Reproductive Medicine
Ovarian Hyperstimulation Syndrome
10/11
10/11
NCT01468441: Ovarian Stimulation Using Recombinant Follicle-stimulating Hormone (FSH) and Gonadotrophin Releasing Hormone (GnRH) Agonist in Alternate Days

Completed
N/A
96
RoW
Triptorelin, Gonapeptyl, Cetrorelix, Cetrotide
Fertility - Assisted Fertilization Center
Infertility
03/12
03/12
NCT01565265: Comparing Ovarian Stimulation for Assisted Reproduction With Two Different Forms of Pituitary Suppression

Completed
N/A
5
Europe
Pergoveris in long protocol with GnRH agonist, Pergoveris, Pergoveris in GnRH antagonist protocol, Cetrotide
University Hospital, Basel, Switzerland, Merck Serono International SA
Female Infertility Due to Nonimplantation of Ovum, Complications Associated With Artificial Fertilization
12/12
12/13

Download Options